Quarterly report pursuant to Section 13 or 15(d)

Cash Equivalents and Marketable Securities - Additional Information (Details)

v3.23.2
Cash Equivalents and Marketable Securities - Additional Information (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash And Cash Equivalents [Line Items]      
Investments in an unrealized loss position $ 26,400,000   $ 139,500,000
Unrealized losses 5,000   $ 626,000
Recognition of other-than-temporary impairment $ 0 $ 0